pmc-enju-pas Home  

PMC:1064895 / 4060-4336 JSONTXT 23 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T3191 12-16 NN denotes bone
T3192 17-27 NN denotes resorption
T3193 28-30 IN denotes by
T3194 31-34 DT denotes the
T3195 35-44 NN denotes induction
T3196 45-47 IN denotes of
T3197 48-53 NN denotes RANKL
T3198 54-55 -LRB- denotes (
T3199 55-63 NN denotes receptor
T3200 64-73 NN denotes activator
T3201 74-76 IN denotes of
T3202 77-84 JJ denotes nuclear
T3203 85-91 NN denotes factor
T3204 92-94 NN denotes κB
T3205 95-96 -LRB- denotes [
T3206 96-101 NN denotes NF-κB
T3207 101-102 -RRB- denotes ]
T3208 103-109 NN denotes ligand
T3209 109-110 -RRB- denotes )
T3210 110-111 -COMMA- denotes ,
T3211 112-117 WDT denotes which
T3212 118-120 VB denotes is
T3213 121-129 VB denotes involved
T3214 130-132 IN denotes in
T3215 133-137 JJ denotes bony
T3216 138-145 NN denotes erosion
T3217 146-148 IN denotes in
T3218 149-151 NN denotes RA
T3219 152-153 -LRB- denotes [
T3220 153-154 CD denotes 7
T3221 154-155 -RRB- denotes ]
T3222 157-159 PRP denotes It
T3223 160-164 RB denotes also
T3224 165-175 VB denotes stimulates
T3225 176-179 DT denotes the
T3226 180-190 NN denotes production
T3227 191-193 IN denotes of
T3228 194-198 NN denotes IL-6
T3229 199-202 CC denotes and
T3230 203-211 NN denotes leukemia
T3231 212-222 JJ denotes inhibitory
T3232 223-229 NN denotes factor
T3233 230-232 IN denotes by
T3234 233-245 NN denotes synoviocytes
T3235 245-246 -COMMA- denotes ,
T3236 247-250 CC denotes and
T3237 251-253 IN denotes of
T3238 254-267 NN denotes prostaglandin
T3239 268-270 NN denotes E2
T3240 271-274 CC denotes and
R1458 T3192 T3191 arg1Of resorption,bone
R1459 T3195 T3193 arg2Of induction,by
R1460 T3195 T3194 arg1Of induction,the
R1461 T3195 T3196 arg1Of induction,of
R1462 T3195 T3198 arg1Of induction,(
R1463 T3195 T3210 arg1Of induction,","
R1464 T3195 T3211 arg1Of induction,which
R1465 T3195 T3212 arg1Of induction,is
R1466 T3195 T3213 arg2Of induction,involved
R1467 T3197 T3196 arg2Of RANKL,of
R1468 T3200 T3198 arg2Of activator,(
R1469 T3200 T3199 arg1Of activator,receptor
R1470 T3200 T3201 arg1Of activator,of
R1471 T3206 T3205 arg2Of NF-κB,[
R1472 T3207 T3205 arg3Of ],[
R1473 T3208 T3201 arg2Of ligand,of
R1474 T3208 T3202 arg1Of ligand,nuclear
R1475 T3208 T3203 arg1Of ligand,factor
R1476 T3208 T3204 arg1Of ligand,κB
R1477 T3208 T3205 arg1Of ligand,[
R1478 T3209 T3198 arg3Of ),(
R1479 T3213 T3212 arg2Of involved,is
R1480 T3213 T3214 arg1Of involved,in
R1481 T3216 T3214 arg2Of erosion,in
R1482 T3216 T3215 arg1Of erosion,bony
R1483 T3216 T3217 arg1Of erosion,in
R1484 T3218 T3217 arg2Of RA,in
R1485 T3218 T3219 arg1Of RA,[
R1486 T3220 T3219 arg2Of 7,[
R1487 T3221 T3219 arg3Of ],[
R1488 T3222 T3224 arg1Of It,stimulates
R1491 T3226 T3224 arg2Of production,stimulates
R1492 T3226 T3225 arg1Of production,the
R1493 T3226 T3227 arg1Of production,of
R1494 T3226 T3237 arg1Of production,of
R1495 T3227 T3236 arg1Of of,and
R1496 T3228 T3229 arg1Of IL-6,and
R1497 T3229 T3227 arg2Of and,of
R1498 T3229 T3233 arg1Of and,by
R1499 T3232 T3229 arg2Of factor,and
R1500 T3232 T3230 arg1Of factor,leukemia
R1501 T3232 T3231 arg1Of factor,inhibitory
R1502 T3234 T3233 arg2Of synoviocytes,by
R1503 T3236 T3235 arg1Of and,","
R1504 T3237 T3236 arg2Of of,and
R1505 T3239 T3238 arg1Of E2,prostaglandin
R1506 T3239 T3240 arg1Of E2,and
R1507 T3240 T3237 arg2Of and,of